Epidemiology and Clinical Features of Human Coronaviruses in the Pediatric Population

Litty Varghese1, Philip Zachariah2, Celibell Vargas2

  • 1Emergency Preparedness Program, North Central Health District, Georgia Department of Public Health, Macon.

Insights

Human coronaviruses (HCoVs) in children often cause mild illness, with few seeking medical attention. However, young age and chronic health conditions increase the risk of severe disease and PICU admission in hospitalized children.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Epidemiology

Background:

  • Human coronaviruses (HCoVs) are common respiratory pathogens, but their epidemiology and clinical impact in children remain incompletely understood.
  • Characterizing HCoV infections in pediatric populations is crucial for public health and clinical management.

Purpose of the Study:

  • To investigate the epidemiology and clinical features of HCoV infections in children.
  • To identify factors associated with severe illness in hospitalized children.

Main Methods:

  • Retrospective study of children with HCoV detected by RT-PCR (2013-2014).
  • Analysis of community and pediatric hospital cohorts.
  • Multivariable logistic regression to assess predictors of severe outcomes in hospitalized children.

Main Results:

  • HCoV was detected in 261 children; community cases were older and less likely to seek medical care.
  • Among hospitalized children, 18.4% required respiratory support and 11.3% were admitted to the PICU.
  • Younger age (<2 years) and chronic complex conditions (CCCs) were associated with increased respiratory support and PICU admission; HCoV type did not influence severity.

Conclusions:

  • Community-acquired HCoV infections in children are generally mild.
  • In hospitalized children, severe outcomes are primarily linked to patient age and underlying chronic conditions, rather than the specific HCoV type.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
51
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.6K